Background and Aim: tr ansrectal ultrasound (trus) -guided prostate biopsy is often a painful procedure. the aim of this study was to evaluate the effectiveness of combining oral paracetamol and codeine with periprostatic nerve block in relieving prostate biopsyrelated pain.
biopsy procedure is painful in up to 90% of the patients (1). Periprostatic nerve block (PNB) has become the gold standardf or pain relief during the prostate biopsy procedure(2) .However,PNB alone does not always sufficiently reduce the pain experienced by patients (3, 4). There have been several attempts to find a better method for pain relief, often by a multimodal approach combining PNB with some other pain medication, e.g. with rofecoxib (5), diclofenac (6) or tramadol (7). Sedation has also beenreported as an alternative method for pain relief, e.g. using midazolam (8) or propofol (9).
Paracetamol is ac ommonly useda nalgesic. The mechanism of the analgesic action of paracetamol is not accurately known, but there is evidence supporting acentral antinociceptive effect (10) . Codeine is a selective μ opioid receptor agonist, which has analgesic effects (11) . Thereisalso evidence supporting a peripheral antinociceptic effect for codeine (12) .
INTRODUCTION
Transrectal ultrasound (TRUS) guided biopsy of the prostate is used to diagnose prostate cancer. As the screening protocols for prostate cancer, as well as active surveillance protocols, are becoming more common, moremen will be exposed to prostate biopsies and repeat biopsies, emphasizing the issue of adequate pain control during the biopsy procedure. The
In our department, PNB using lidocaine is the routine method for pain relief during prostate biopsy. We have observed anxiety and pain in several patients, despite PNB. Therefore, we have started to treat patients with the combination of 500 mg paracetamol and 30 mg codeine orally prior to the biopsy procedure, in addition to PNB. The aim of this pilot study was to evaluate the efficacy of the combination of oral paracetamol, codeine and PNB in the treatment of pain caused by TRUS-guided prostate biopsy.
MATERIAl AND METHODS
Atotal of 50 patients who underwent prostate biopsies for diagnosing prostate cancer at the out-patient clinic of our institution between November 2006 and May 2007 were selected for this prospective study. The study population consists of 25 consecutive patients who received paracetamol and codeine orally beforet he biopsy,i na ddition to PNB (group 1), and 25 consecutive patients with PNB as their only pain relief (group 2). Informed consent was obtained from all patients before the biopsy.
All patients received ciprofloxacin 500 mg orally 1hour beforet he biopsy,a nd another 500 mg of ciprofloxacin in the evening after the procedure. All patients received a routine PNB, using 10 ml of 1% lidocaine injected to four locations( lateral to the seminal vesicles and apically on both sides, 2.5 ml per each location) under TRUS guidance. 25 patients (group 1) also received paracetamol 500 mg and codeine 30 mg orally (Panacod ® ,s anofi-aventis, France) 1 hour beforet he procedure, whereas 25 patients did not (group 2). Prostate biopsies were taken from 12 locations using TRUS guidance according to our department's routine protocol (2 biopsies from the base, mid-gland, and apex bilaterally). All biopsies wereperformed by the same urology resident (H.V.). The patients wereasked to evaluate the overall pain associated with the biopsy procedure immediately after the biopsy,using astandardlinear 10-point visual analogue scale (VAS).
The results arepresented as mean ±standarddeviation (SD). Astandardt-test was performed to comparethe two groups statistically.
RESUlTS
The clinicopathologic data are listed in Table 1 . The study groups were well matched by age, prostate volume and PSA. The individual pain scores are reported in Fig. 1 . The mean pain scorei ng roup 1w as 
DISCUSSION
The TRUS-guided needle biopsy of the prostate is often painfulfor the patient.Periprostatic nerveblock (PNB) using lidocaine has become the gold standard for prostate biopsy procedure. Despite PNB, however, approximately 20% of patients experience significant pain during the procedure (13) . In the current study we show that analgesia for prostate biopsy can be improved by amultimodal approach combining oral paracetamol and codeine with PNB. Several multimodal approaches for pain control during biopsies have been reported (5-7, 13). Some seem to be ineffective, while some are effective but the analgesics used require additional patient monitoring and may have central nervous system sideeffects. The oral analgesics used in this study, paracetamol and codeine, are safe and well-tolerated. Both are hypothesized to have both central and peripheral antinociceptic effects. Tramadol, another μ opioid receptor agonist, combined with PNB was shown to decrease the biopsy pain compared to PNB alone (13) . Due to the side-effects of tramadol (e.g. sedation, nausea, vomiting), however,some authors do not recommend tramadol to be used in the treatment of acute pain (14) . No side-effects emerged in our study, which might favor the use of codeine instead of tramadol.
Among the obvious limitations of our current study aret he small number of patients and the fact that the patients weren ot randomized. Despite the small number of patients, however, the study patients represent well the general biopsy population, demonstrated by patient characteristics and biopsy diagnoses (Table 1) . Neither a placebo group nor a group with oral analgesics only was included in this study, because we considered it ethical to offer all patients PNB as it has become the gold standardi nt reating biopsy-related pain.
The difference in VA Ss cores between the two groups was statistically significant (p =0 .01). The mean VA Sscoreinboth groups was low (1.4 in group 1 and 2.4 in group 2), emphasizing the fact that PNB alone is effective in alleviating biopsy pain. The distribution of VA S scores suggests, however, that a subgroup of patients might benefit markedly by using oral paracetamol and codeine in addition to PNB, as the VA S scores of seven patients (28%) in group 2 were more than 3, which we consider significant pain. In group 1, in contrast, all patients had VA S scores less than 3. In one published study the biopsy was most painful for those patients with most pre-biopsy anxiety (15) , supporting the idea thatcentrally acting analgesics such as codeine may improve analgesia beyond local PNB.
In conclusion, our study shows that the combination of paracetamol, codeine and PNB may be better in controlling biopsy-related pain than PNB alone, allowing the biopsy procedure to be carried out safely in an out-patient setting. Randomized studies confirming our results are warranted.
